Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXIR0I
|
||||
Drug Name |
5-Benzo[1,3]dioxol-5-yl-6-[(4-cyano-phenyl)-(3-methyl-3H-imidazol-4-yl)-methoxymethyl]-1-methyl-2-oxo-1,2-dihydro-pyridine-3-carbonitrile
|
||||
Synonyms |
CHEMBL130185
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C27H21N5O4
|
||||
Canonical SMILES |
CN1C(=C(C=C(C#N)C1=O)c2ccc3OCOc3c2)COC(c4ccc(cc4)C#N)c5cncn5C
|
||||
InChI |
InChI=1S/C27H21N5O4/c1-31-15-30-13-22(31)26(18-5-3-17(11-28)4-6-18)34-14-23-21(9-20(12-29)27(33)32(23)2)19-7-8-24-25(10-19)36-16-35-24/h3-10,13,15,26H,14,16H2,1-2H3
|
||||
InChIKey |
CRPNIZNJBGVBMQ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.